Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Si-Bone Inc
SIBNCurrent price
14.82 USD
-0.14 USD (-0.94%)
Last closed
14.66 USD
Company
si-bone.com
ISIN
US8257041090
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
577 489 024 USD
Yield for 12 month
-2.18 %
1Y
3Y
5Y
10Y
15Y
SIBN
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. Address: 471 El Camino Real, Santa Clara, CA, United States, 95050
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
22.78 USDP/E ratio
–Dividend Yield
–Current Year
+138 886 000 USD
Last Year
+106 409 000 USD
Current Quarter
+40 340 000 USD
Last Quarter
+39 969 000 USD
Current Year
+109 420 000 USD
Last Year
+90 704 000 USD
Current Quarter
+31 903 000 USD
Last Quarter
+31 576 000 USD
Key Figures SIBN
1 year
3 years
5 years
10 years
EBITDA
-37 521 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-11.54 %
PEG Ratio
–
Return On Equity TTM
-22.09 %
Wall Street Target Price
22.78 USD
Revenue TTM
157 035 008 USD
Book Value
3.95 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
18.60 %
Dividend Yield
–
Gross Profit TTM
90 704 000 USD
Earnings per share
-0.91 USD
Diluted Eps TTM
-0.91 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-23.82 %
Dividend Analytics SIBN
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History SIBN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation SIBN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
2.87
Price Sales TTM
3.68
Enterprise Value EBITDA
-14.15
Price Book MRQ
3.41
Financials SIBN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SIBN
For 52 weeks
11.70 USD
21.70 USD
50 Day MA
13.41 USD
Shares Short Prior Month
1 268 860
200 Day MA
14.52 USD
Short Ratio
2.47
Shares Short
1 110 912
Short Percent
3.01 %
BeatStart